UPLC-MS /MS determination of tanshinone ⅡA,salvianolic acid B and ginsenoside Rg1 in Fufang Danshen preparation in rat plasma and brain tissues
张杰,刘胜兰,王慧,阳国平,李劲平,刘世坤,唐智,裴奇,黄攀豪
DOI: https://doi.org/10.19540/j.cnki.cjcmm.2017.0014
2017-01-01
China Journal of Chinese Materia Medica
Abstract:A sensitive and specific ultra-performance liquid chromatography-mass spectrometry (UPLC-MS /MS)method was devel-oped for analysis of tanshinone ⅡA (TSⅡA ),salvianolic acid B(SAB)and ginsenoside Rg1 (GRg1 )in rat plasma and brain tissues. Male healthy Sprague-Dawley(SD)rats were orally given single dose of Fufang Danshen preparation (TS ⅡA 60 mg·kg -1 ,SAB 300 mg·kg -1 ,GRg1150 mg·kg -1 ,borneol 300 mg·kg -1 ),and their blood samples and brain tissues were collected at different time points.The drug plasma and brain tissue concentrations of the three analytes were determined by UPLC-MS /MS method.Subsequently, the main pharmacokinetics parameters of plasma and brain tissues were calculated by using Phoenix WinNolin 6.1 software.The meth-odological test showed that all of analytes in both plasma and brain homogenate exhibited a good linearity within the concentration range (r >0.9922).Their mean recoveries were between 58.86% and 112.1%.Intra-day and inter-day precisions of the investigated com-ponents exhibited RSD≤9.7%,and the accuracy(RE)ranged from -9.68% to 8.20% at all quality control levels.The results of accuracy and stability meet the requirements for biopharmaceutical analysis.For TSⅡA ,the pharmacokinetics parameters Tmax ,Cmax , AUC0-t ,MRTlast in the plasma were (1.58 ±0.081)h,(725.4 ±88.20)μg·L -1 ,(2101.3 ±124.85)μg·h·L -1 and (3.66 ± 0.05)h,respectively.For SAB,the pharmacokinetics parameters Tmax ,Cmax ,AUC0-t ,MRTlast in the plasma were (1.29 ±0.21)h, (307.9 ±46.75)μg·L -1 ,(537.4 ±88.24)μg·h·L -1 and (2.08 ±0.11)h,respectively.For GRg1 ,the pharmacokinetics pa-rameters Tmax ,Cmax ,AUC0-t ,MRTlast in the plasma were (1.42 ±0.20)h,(460.38 ±154.60)μg·L -1 ,(383.4 ±88.16)μg·h ·L -1 and (1.87 ±0.046)h,respectively.For TSⅡA ,the pharmacokinetics parameters Tmax ,Cmax ,AUC0-t ,MRTlast in the brain tis-sue were (0.75 ±0.22)h,(1.41 ±0.42)ng·g -1 ,(4.34 ±2.48)ng·h·g -1 and (4.00 ±1.90)h,respectively.For SAB,the pharmacokinetics parameters Tmax ,Cmax ,AUC0-t ,MRTlast in the plasma were (1.08 ±0.20 )h,(21.09 ±4.850 )ng · g -1 , (14.83 ±3.160)ng·h·g -1 and (0.99 ±0.08)h,respectively.For GRg1 ,the pharmacokinetics parameters Tmax ,Cmax ,AUC0-t , MRTlast in the plasma were (0.50 ±0.16)h,(130.96 ±54.220)ng·g -1 ,(136.24 ±34.350)ng·h·g -1 and (2.87 ±0.33)h, respectively.The developed method was successfully applied in pharmacokinetic studies on content of TS ⅡA ,SAB and GRg1 in rat plasma and brain tissues.